Eyetelligence, an Australian-based leading innovator in AI-powered healthcare solutions, will showcase its cutting-edge eye screening software at O=MEGA23 in Melbourne from 7 – 9 September.
The company’s advanced AI technology analyses full-colour fundus images to screen for referrable eye diseases including glaucoma, diabetic retinopathy, and age-related macular degeneration. Additionally, the technology can screen for cardiovascular diseases and provide a risk assessment profile.
Delegates to O=MEGA23 are invited to go ‘Eye to Eye with AI’ when they visit Eyetelligence at booth B12. Experience first-hand how this ground-breaking software is changing the landscape of eye health… and discover how Eyetelligence technology enhances accuracy, speed, and accessibility in eye screening.